Funding The study was partially funded by Pfizer (New York, NY, USA)
Yet, when someone with B12 deficiency reports that symptoms re-occur 4-5 weeks after a B12 injection, and wants to inject more often, all of a sudden, this person is mislabelled as suffering from the placebo effect of B12 injections
Summary Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year
The Benefits: It can help to boost mood, energy, and concentration - especially during times of stress
Talk to on of our providers to see if GLP-1 therapy like tirzepatide might be right for you
Cycle 8-12 weeks on, 4-8 weeks off